We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current SBTX market cap is 24.02M. The company's latest EPS is GBP -0.0125 and P/E is -8.50.
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 0 | 0 | 0 | 75k | 132k |
| Operating Income | -1.36M | -1.62M | -1.49M | -2.98M | -2.97M |
| Net Income | -1.15M | -1.5M | -1.43M | -2.79M | -2.84M |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 3.93M | 2.77M | 5.74M | 3.09M | 2.59M |
| Total Liabilities | 121k | 305k | 520k | 610k | 599k |
| Total Equity | 3.81M | 2.47M | 5.22M | 2.48M | 2M |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | -1.43M | -892k | -1.56M | -2.67M | -2.65M |
| Investing | -69k | -74k | -112k | -97k | -165k |
| Financing | 1.44M | N/A | 4.12M | -35k | 2.32M |
| Market Cap | 24.02M |
| Price to Earnings Ratio | -8.50 |
| Price to Sales Ratio | 177 |
| Price to Cash Ratio | 18.31 |
| Price to Book Ratio | 12.04 |
| Dividend Yield | - |
| Shares Outstanding | 226.09M |
| Average Volume (1 week) | 496.92k |
| Average Volume (1 Month) | 1.46M |
| 52 Week Change | -48.17% |
| 52 Week High | 29.50 |
| 52 Week Low | 7.25 |
| Spread (Intraday) | 0.25 (2.33%) |
| Company Name | Skinbiotherapeutics Plc |
| Address |
the core bath lane newcastle upon tyne NE4 5TF |
| Website | https://www.skinbiotherapeutics.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
